Chronic care focus Target health systems and specialty clinics focusing on heart failure and chronic disease management to integrate Bodyport’s noninvasive biomarkers and home-based monitoring as an adjunct to existing care pathways.

Clinical validation Leverage ongoing SCALE-HF study and partnerships (e.g., Geisinger) to position the platform as evidence-backed for predicting heart failure events, opening opportunities with payers and hospital networks demanding proven outcomes.

Digital health stack Prospect hospitals and health systems already using AWS, Salesforce, PostgreSQL and other listed technologies; propose seamless integration into their IT ecosystem and CRM workflows to accelerate adoption.

Growth through leadership Capitalize on leadership appointments and board activity to engage enterprise buyers; reach C-suite and clinical governance teams highlighting strategic direction, risk reduction, and scalability.

Expansion potential Explore cross-condition applications beyond heart failure; partner with multidisciplinary teams to expand into other chronic diseases, increasing addressable market and depth of clinical utility.